Related Experiment Video
Updated: Aug 17, 2026

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
Published on: October 11, 2019
Squalamine: a polyvalent drug of the future?
Jean Michel Brunel1, Chanaz Salmi, Celine Loncle
1Laboratoire SESNAB Faculté de St Jérôme, Université Paul Cézanne, Av. Escadrille Normandie Niemen, 13397 Marseille, Cedex 20, France. bruneljm@yahoo.fr
Abstract:
The purpose of this mini-review is to summarize and highlight the different advances in our understanding of the antimicrobial and antiangiogenic activity of squalamine, a cationic steroid isolated in 1993 from the dogfish shark Squalus Acanthias. Indeed, squalamine has shown to be useful for the treatment of important diseases such as cancers (lung, ovarian, brain and others), age-related macular degeneration (AMD) and the control of body weight in man. All these results led to a question: could we consider squalamine as a polyvalent drug of the future?
Related Concept Videos
Antiprotozoal Agents
Anthelminthic Agents
Antihypertensive Drugs: Potassium-Sparing Diuretics
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pharmacogenomics: Identification of New Drug Targets